洗口液市場 – 2030年までの世界予測

本レポートは、洗口液市場の分析を提供し、流通チャネル、地域、適応症、製品タイプなど、様々なセグメントにおける市場規模と将来の成長可能性の推定に重点を置いています。さらに、主要市場プレーヤーの競合分析も掲載しており、企業概要、製品・サービス内容、最近の動向、主要戦略などを詳細に解説しています。

本レポートは、洗口液セクターの業界リーダーと新規参入企業にとって重要な洞察を提供し、市場全体と各セグメントの推定収益予測を提示しています。本レポートは、競争環境を包括的に理解し、関係者が自社の効果的なポジショニングと強力な市場開拓戦略の策定を支援します。さらに、主要な市場推進要因、制約、課題、そして機会を詳細に分析することで、関係者が現在の市場状況を高い精度で評価できるよう支援します。

先進的なオーラルケア製品への意識の高まりと世界人口の増加は、洗口液市場の成長を牽引すると予想されています。フッ化物、エッセンシャルオイル、ハーブ系有効成分、アルコールフリー基剤の使用など、製剤技術の継続的な革新により、製品の有効性、安全性、そして消費者への訴求力が向上しています。これらの改良により、洗口液の有効性、入手性、そして魅力は、より幅広い顧客層や臨床用途において高まっています。歯科疾患の増加や、より高度なオーラルケアを必要とする高齢化も、需要の増加につながっています。しかしながら、治療用洗口液の高価格や、一部の市場では消費者の受容性や遵守率が低いことから、市場への普及は限定的となる可能性があります。

Growing awareness of advanced oral care products, along with a rising global population, is expected to drive the growth of the oral rinses market. Continuous innovation in formulation technologies, including the use of fluoride variants, essential oils, herbal actives, and alcohol-free bases, is improving product effectiveness, safety, and appeal to consumers. These improvements are increasing the effectiveness, availability, and attractiveness of oral rinses to a broader range of customers and clinical uses. Demand is also growing due to an increase in dental diseases and an aging population in need of additional oral care. However, broader market adoption may be limited by the high cost of therapeutic mouthwash and, in some markets, low consumer acceptance or adherence.

By product type, the therapeutic rinses segment had the largest share of the global oral rinses market.

The global oral rinses market is divided into three main segments: therapeutic rinses, cosmetic rinses, and others. The therapeutic rinses segment dominates the oral hygiene market due to their significant functional advantages and clinical endorsement. These formulations are enriched with active agents that effectively lower bacterial loads, mitigate the risk of periodontal diseases, and promote enamel integrity. They are specifically engineered to address the etiology of oral health issues rather than merely alleviating symptoms. Key drivers for their adoption include professional recommendations from dentists, an increasing consumer emphasis on long-term oral health maintenance, and heightened awareness of the correlation between oral health and systemic conditions. The accessibility of these products in both clinical environments and retail outlets further amplifies their market penetration.

The general oral health segment commanded the largest share of the global oral rinses market based on indication.

The global oral rinses market is divided into several categories based on indication: general oral health, gingivitis & periodontal diseases, halitosis, dry mouth, and other conditions. The general oral health segment is anticipated to command the largest share of the market due to its expansive positioning, enabling manufacturers to engage a diverse consumer base, including individuals focused on preventive oral care. Contributing factors to this segment’s growth include enhanced accessibility, minimal regulatory constraints, and robust retail visibility. Furthermore, strategic brand-centric marketing initiatives have been pivotal in embedding general-use mouthwashes into daily personal care regimens globally, thereby reinforcing their market dominance. This segment exhibits relatively stable demand trajectories, making it an appealing prospect for long-term investment strategies. Leading industry players have consistently prioritized this category within their portfolios, recognizing it as a principal contributor to sales volume and market share expansion.

By distribution channel, the consumer stores segment accounted for the largest share of the global oral rinses market.

The global oral rinses market is divided by distribution channel into consumer stores, retail pharmacies & dental dispensaries, and online sales. Consumer retail outlets dominate the oral rinses market, attributed to their extensive physical presence, high in-store brand visibility, and the convenience they afford to everyday shoppers. Supermarkets and general retail establishments facilitate direct access to a diverse range of products, enabling consumers to easily compare brands. Additionally, these venues frequently implement promotional strategies and incentives that stimulate impulse purchasing behaviors. The integration of oral care products into routine grocery shopping significantly boosts sales volumes through this channel. Furthermore, established collaborations with fast-moving consumer goods (FMCG) distributors and optimized shelf placement strategies enhance their competitive advantage within the market.

The Asia Pacific is expected to grow at the highest CAGR in the oral rinses market during the forecast period.

The rapid growth of the population in the Asia Pacific region, coupled with a rising demand for sophisticated oral care solutions, is significantly driving the market for oral rinses. As the middle class expands, consumer interest in maintaining oral health has surged, leading to a greater emphasis on the importance of effective oral hygiene products. In response to these trends, leading global companies in the oral care industry are strategically increasing their presence in this dynamic market. They are doing so by introducing innovative formulations that cater to diverse needs, such as whitening, sensitivity relief, and antibacterial properties, as well as launching digitally integrated oral hygiene solutions that promote seamless user experiences. Moreover, indication-specific mouthwashes designed to target particular oral health issues are becoming increasingly popular, further contributing to the robust demand for oral rinses across the region.

A breakdown of the primary participants (supply side) for the oral rinses market referred to in this report is provided below:

• By Company Type: Tier 1 (30%), Tier 2 (35%), and Tier 3 (35%)
• By Designation: C-level Executives (20%), Directors (35%), and Others (45%)
• By Region: North America (30%), Europe (25%), Asia Pacific (20%), Latin America (20%), Middle East & Africa (2%), GCC Countries (3%)

Prominent players in the oral rinses market include Colgate-Palmolive Company (US), Kenvue (US), Procter & Gamble (US), Haleon Group of Companies (UK), Unilever (UK), Church & Dwight Co., Inc. (US), Lion Corporation (Japan), Amway (US), SUNSTAR Suisse S.A. (Switzerland), Perrigo Company plc (Ireland), Dabur (India), Himalaya Wellness Company (India), Kao Corporation (Japan), Opella Healthcare Group SAS (France), SmartMouth Oral Health Laboratories (US), Dentaid Ltd. (Spain), CloSYS (US), SCANDERRA GmbH (Switzerland), Pearlie White (Singapore), Dr. Wild & Co. AG (Switzerland), Boka (US), Perfora (India), Salt Oral Care (India), OraBio, Inc. (US), and Lumineux (US).

Research Coverage

The report offers an analysis of the oral rinses market, focusing on estimating the market size and potential for future growth across various segments, including distribution channels, regions, indications, and product types. Additionally, the report includes a competitive analysis of major market players, detailing their company profiles, product and service offerings, recent developments, and key strategies.

Reasons to Buy the Report

The report delivers critical insights for industry leaders and new entrants within the oral rinses sector, presenting estimated revenue projections for the overall market as well as its distinct segments. It facilitates a comprehensive understanding of the competitive landscape, enabling stakeholders to effectively position their businesses and devise robust go-to-market strategies. Furthermore, the document delineates key market drivers, constraints, challenges, and opportunities, equipping stakeholders to evaluate prevailing market conditions with a high degree of accuracy.

This report provides insights into the following pointers:

Analysis of key drivers (high incidence of dental diseases, product innovation and advanced formulations), restraints (side effects from prolonged use, competition from alternative products), opportunities (rising trend of online purchasing and e-commerce, growing awareness about oral hygiene), and challenges (limited penetration in rural areas, high price points limit broader consumer adoption).

• Market Penetration: This report provides detailed information on the product portfolios offered by major players in the global oral rinses market. It covers various segments, including product types, indications, distribution channels, and regions.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global oral rinses market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by product type, indication, distribution channel, and region.
• Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global oral rinses market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products and services, and capacities of the major competitors in the global oral rinses market.

Table of Contents

1               INTRODUCTION              24

1.1           STUDY OBJECTIVES       24

1.2           MARKET DEFINITION   24

1.3           STUDY SCOPE   25

1.3.1        ORAL RINSES MARKET SEGMENTATION & REGIONAL SCOPE  25

1.3.2        INCLUSIONS & EXCLUSIONS       26

1.3.3        YEARS CONSIDERED      27

1.3.4        CURRENCY CONSIDERED            27

1.4           STAKEHOLDERS               28

2               RESEARCH METHODOLOGY       29

2.1           RESEARCH DATA              29

2.1.1        SECONDARY DATA          30

2.1.1.1    Key secondary sources         30

2.1.1.2    Key data from secondary sources       31

2.1.2        PRIMARY DATA 31

2.1.2.1    Objectives of primary research           32

2.1.2.2    Key data from primary sources           32

2.1.2.3    Key industry insights           33

2.2           MARKET SIZE ESTIMATION         34

2.2.1        REVENUE SHARE ANALYSIS         34

2.2.2        BOTTOM-UP APPROACH (SUPPLY-SIDE ANALYSIS)                 37

2.2.3        COMPANY PRESENTATIONS & PRIMARY INTERVIEWS                 37

2.2.4        TOP-DOWN APPROACH                39

2.3           DATA TRIANGULATION                39

2.4           MARKET SHARE ESTIMATION    40

2.5           STUDY ASSUMPTIONS  40

2.6           RESEARCH LIMITATIONS             41

2.6.1        SCOPE-RELATED LIMITATIONS                 41

2.6.2        METHODOLOGY-RELATED LIMITATIONS           41

2.7           RISK ANALYSIS  41

3               EXECUTIVE SUMMARY  42

4               PREMIUM INSIGHTS       45

4.1           ORAL RINSES MARKET OVERVIEW           45

4.2           ASIA PACIFIC: ORAL RINSES MARKET, BY PRODUCT TYPE AND COUNTRY     46

4.3           ORAL RINSES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              47

4.4           ORAL RINSES MARKET: REGIONAL MIX 47

4.5           ORAL RINSES MARKET: DEVELOPED VS. EMERGING MARKETS, 2025 VS. 2030 48

5               MARKET OVERVIEW       49

5.1           INTRODUCTION              49

5.2           MARKET DYNAMICS       49

5.2.1        DRIVERS               50

5.2.1.1    High incidence of chronic dental diseases        50

5.2.1.2    Increasing household purchasing power of middle-class population in emerging economies    50

5.2.1.3    Rising focus on creating public awareness and targeted educational campaigns        50

5.2.2        RESTRAINTS      51

5.2.2.1    High cost of therapeutic and specialty formula-based oral rinses                 51

5.2.2.2    Side effects from prolonged use of therapeutic and alcohol-based mouthwashes         51

5.2.3        OPPORTUNITIES              51

5.2.3.1    Rising trends of online purchasing and e-commerce      51

5.2.4        CHALLENGES    52

5.2.4.1    Rising number of product recalls       52

5.2.4.2    Limited penetration in rural and semi-urban areas in emerging economies              52

5.3           INDUSTRY TRENDS         53

5.3.1        STRATEGIC DEMERGER OF CONSUMER HEALTHCARE DIVISIONS BY LEADING PHARMACEUTICAL COMPANIES                 53

5.3.2        RISE OF NATURAL AND HERBAL ORAL RINSES AMID CLEAN-LABEL CONSUMER SHIFT             53

5.4           TECHNOLOGY ANALYSIS             54

5.4.1        KEY TECHNOLOGIES     54

5.4.1.1    Flouride 54

5.4.1.2    Anti-microbial agents          54

5.4.2        COMPLEMENTARY TECHNOLOGIES       54

5.4.2.1    Essential oils          54

5.4.3        ADJACENT TECHNOLOGIES       55

5.4.3.1    Electric dental flossers         55

5.5           PRICING ANALYSIS          55

5.5.1        AVERAGE SELLING PRICE TREND OF ORAL RINSES, BY KEY PLAYER,

2022–2024              55

5.5.2        AVERAGE SELLING PRICE TREND OF ORAL RINSES, BY REGION, 2022–2024           55

5.6           ECOSYSTEM ANALYSIS  56

5.6.1        ROLE IN ECOSYSTEM     57

5.7           REIMBURSEMENT SCENARIO ANALYSIS                 58

5.8           VALUE CHAIN ANALYSIS               58

5.9           PORTER’S FIVE FORCES ANALYSIS           59

5.9.1        INTENSITY OF COMPETITIVE RIVALRY 61

5.9.2        BARGAINING POWER OF SUPPLIERS       61

5.9.3        BARGAINING POWER OF BUYERS             61

5.9.4        THREAT OF SUBSTITUTES          61

5.9.5        THREAT OF NEW ENTRANTS      61

5.10         KEY STAKEHOLDERS & BUYING CRITERIA            62

5.10.1      KEY STAKEHOLDERS IN BUYING PROCESS           62

5.10.2      KEY BUYING CRITERIA  62

5.11         SUPPLY CHAIN ANALYSIS             63

5.12         TRADE ANALYSIS             64

5.12.1      IMPORT DATA FOR HS CODE 330690, 2020–2024  64

5.12.2      EXPORT DATA FOR HS CODE 330690, 2020–2024  65

5.13         REGULATORY ANALYSIS               65

5.13.1      REGULATORY FRAMEWORK       65

5.13.1.1  North America      65

5.13.1.1.1                US           65

5.13.1.2  European Union   66

5.13.1.3  Asia Pacific            66

5.13.1.3.1                China      66

5.13.2      REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  67

5.14         PATENT ANALYSIS          69

5.14.1      PATENT PUBLICATION TRENDS FOR ORAL RINSES MARKET               69

5.14.2      JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN

ORAL RINSES MARKET  69

5.14.3      LIST OF MAJOR PATENTS             71

5.15         KEY CONFERENCES & EVENTS, 2025–2026              72

5.16         ADJACENT MARKET ANALYSIS  73

5.17         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       73

5.18         UNMET NEEDS/END-USER EXPECTATIONS         74

5.18.1      UNMET NEEDS 74

5.18.2      END-USER EXPECTATIONS         75

5.19         IMPACT OF AI/GEN AI ON ORAL RINSES MARKET                 75

5.20         CASE STUDY ANALYSIS 76

5.20.1      CAPHOSOL ORAL RINSE TO EFFECTIVELY MANAGE

CHEMOTHERAPY-INDUCED ORAL MUCOSITIS 76

5.20.2      ANTISPECTIC MOUTHWASHES TO PREVENT VENTILATOR-ASSOCIATED PNEUMONIA (VAP) AMONG MECHANICALLY VENTILATED PATIENTS             77

5.20.3      HERBAL MOUTHRINSE TO BE EFFECIVE FOR CHLORHEXIDINE WITHOUT ADVERSE EFFECTS                77

5.21         INVESTMENT & FUNDING SCENARIO     78

5.22         IMPACT OF 2025 US TARIFF ON ORAL RINSES MARKET                 78

5.22.1      INTRODUCTION              78

5.22.2      KEY TARIFF RATES          79

5.22.3      KEY TARIFF RATES          79

5.22.4      PRICE IMPACT ANALYSIS             80

5.22.5      IMPACT ON COUNTRY/REGION                80

5.22.5.1  North America      80

5.22.5.1.1                US           80

5.22.5.2  Europe   80

5.22.5.3  Asia Pacific            81

5.22.6      IMPACT ON END-USE INDUSTRIES          81

6               ORAL RINSES MARKET, BY PRODUCT TYPE         82

6.1           INTRODUCTION              83

6.2           THERAPEUTIC RINSES  83

6.2.1        INCREASING PREVALENCE OF ORAL DISEASES TO

BOOST ADOPTION OF THERAPEUTIC RINSES    83

6.3           COSMETIC RINSES           84

6.3.1        RISE IN AESTHETIC CONSCIOUSNESS TO PROMOTE

ADOPTION OF COSMETIC RINSES            84

6.4           OTHER RINSES 86

7               ORAL RINSES MARKET, BY INDICATION                88

7.1           INTRODUCTION              89

7.2           GENERAL ORAL HEALTH              89

7.2.1        GENERAL USE MOUTHWASHES TO REDUCE PLAQUE, FRESHEN BREATH, SUPPORT GUM HEALTH, AND ENHANCE ORAL CLEANLINESS       89

7.3           GINGIVITIS & PERIODONTAL DISEASES                90

7.3.1        WIDESPREAD PREVALENCE OF GUM-RELATED CONDITIONS AND HIGH DEMAND FOR NON-INVASIVE TREATMENTS TO DRIVE MARKET            90

7.4           HALITOSIS          92

7.4.1        RISING AESTHETIC CONSCIOUSNESS TO FUEL ADOPTION OF ORAL RINSES FOR BAD BREATH 92

7.5           DRY MOUTH      93

7.5.1        RISING GERIATRIC POPULATION WITH CHRONIC DISEASES TO PROPEL SEGMENT GROWTH          93

7.6           OTHER INDICATIONS   94

8               ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL                 96

8.1           INTRODUCTION              97

8.2           CONSUMER STORES       97

8.2.1        BROAD ACCESSIBILITY, IN-STORE MARKETING, AND SEASONAL PROMOTIONS TO INCREASE SALES IN CONSUMER STORE  97

8.3           RETAIL PHARMACIES & DENTAL DISPENSARIES                 99

8.3.1        STRONG CLINICAL ENDORSEMENT AND INCREASED CONSUMER TRUST TO FUEL SALES OF ORAL RINSES     99

8.4           ONLINE DISTRIBUTION                100

8.4.1        RISE IN INTERNET USE, EVOLVED DIGITAL SHOPPING HABITS, AND CONVENIENCE OF DIRECT-TO-DOOR DELIVERY TO DRIVE MARKET         100

9               ORAL RINSES MARKET, BY REGION         102

9.1           INTRODUCTION              103

9.2           NORTH AMERICA             104

9.2.1        MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 104

9.2.2        US           107

9.2.2.1    US to dominate North American oral rinses market during forecast period      107

9.2.3        CANADA               109

9.2.3.1    Better network of dental professionals and robust healthcare infrastructure to propel market growth             109

9.3           EUROPE               111

9.3.1        MACROECONOMIC OUTLOOK FOR EUROPE      111

9.3.2        GERMANY           113

9.3.2.1    High prevalence of edentulism and willingness to invest in advanced personal care products to augment market growth        113

9.3.3        UK          115

9.3.3.1    Rising geriatric population and increasing demand for oral hygiene products to encourage market growth                115

9.3.4        FRANCE                117

9.3.4.1    Persistent burden of dental diseases and favorable government initiatives to spur market growth       117

9.3.5        ITALY    118

9.3.5.1    Aging demographic and prevalence of chronic dental diseases to aid market growth                 118

9.3.6        SPAIN    120

9.3.6.1    Strong dental care infrastructure and high focus on quality healthcare to support market growth                 120

9.3.7        SWITZERLAND 122

9.3.7.1    Focus on high standard of living to drive popularity of advanced oral hygiene products           122

9.3.8        POLAND               123

9.3.8.1    Strong public healthcare system and wider access to high-quality dental care products to propel market growth 123

9.3.9        REST OF EUROPE             125

9.4           ASIA PACIFIC     126

9.4.1        MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 127

9.4.2        CHINA  130

9.4.2.1    Focus on oral hygiene and high burden of age-related dental conditions to fuel demand for preventive oral care products         130

9.4.3        JAPAN   132

9.4.3.1    Strong dental health awareness and presence of key players to augment market growth      132

9.4.4        INDIA    133

9.4.4.1    Increasing awareness about dental health and growing consumer purchasing power to support market growth   133

9.4.5        AUSTRALIA         135

9.4.5.1    Favorable government initiatives and high incidence of dental diseases to accelerate market growth 135

9.4.6        SOUTH KOREA  137

9.4.6.1    Rising disposable income and increasing demand for advanced dental care solutions to favor market growth   137

9.4.7        REST OF ASIA PACIFIC   139

9.5           LATIN AMERICA                140

9.5.1        MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 140

9.5.2        BRAZIL 142

9.5.2.1    High rate of urbanization to sustain demand for quality oral care products 142

9.5.3        MEXICO                144

9.5.3.1    Easy access to modern dental clinics, pharmacies, and e-commerce platforms to aid market growth       144

9.5.4        REST OF LATIN AMERICA             146

9.6           MIDDLE EAST & AFRICA                147

9.6.1        EASY AVAILABILITY OF ORAL CARE PRODUCTS THROUGH URBAN CONVENIENCE STORES AND E-COMMERCE TO DRIVE MARKET         147

9.6.2        MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 148

9.7           GCC COUNTRIES              149

9.7.1        INCREASING DEMAND FOR ADAVNCED DENTAL CARE SERVICES TO AUGMENT MARKET GROWTH       149

9.7.2        MACROECONOMIC OUTLOOK FOR GCC COUNTRIES                 150

10            COMPETITIVE LANDSCAPE         152

10.1         INTRODUCTION              152

10.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            152

10.2.1      OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ORAL RINSES MARKET          153

10.3         REVENUE ANALYSIS, 2020–2024  154

10.4         MARKET SHARE ANALYSIS, 2024                 154

10.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 156

10.5.1      STARS   156

10.5.2      EMERGING LEADERS     157

10.5.3      PERVASIVE PLAYERS      157

10.5.4      PARTICIPANTS 157

10.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         159

10.5.5.1  Company footprint               159

10.5.5.2  Region footprint   160

10.5.5.3  Product type footprint         161

10.5.5.4  Indication footprint              162

10.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        163

10.6.1      PROGRESSIVE COMPANIES         163

10.6.2      RESPONSIVE COMPANIES            163

10.6.3      DYNAMIC COMPANIES  163

10.6.4      STARTING BLOCKS         163

10.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 165

10.6.5.1  Detailed list of key startups/SMEs    165

10.6.5.2  Competitive benchmarking of key startups/SMEs          165

10.7         COMPANY VALUATION & FINANCIAL METRICS 166

10.7.1      FINANCIAL METRICS      166

10.7.2      COMPANY VALUATION 166

10.8         BRAND/PRODUCT COMPARISON             167

10.9         R&D EXPENDITURE OF KEY PLAYERS     168

10.10       COMPETITIVE SCENARIO             168

10.10.1   PRODUCT LAUNCHES   168

10.10.2   DEALS  169

10.10.3   EXPANSIONS     170

10.10.4   OTHER DEVELOPMENTS              170

11            COMPANY PROFILES      171

11.1         KEY PLAYERS     171

11.1.1      KENVUE               171

11.1.1.1  Business overview 171

11.1.1.2  Products offered   172

11.1.1.3  Recent developments           174

11.1.1.3.1                Product launches  174

11.1.1.3.2                Deals      174

11.1.1.3.3                Expansions             174

11.1.1.4  MnM view              175

11.1.1.4.1                Right to win           175

11.1.1.4.2                Strategic choices   175

11.1.1.4.3                Weaknesses & competitive threats     175

11.1.2      COLGATE-PALMOLIVE COMPANY           176

11.1.2.1  Business overview 176

11.1.2.2  Products offered   177

11.1.2.3  Recent developments           178

11.1.2.3.1                Product launches  178

11.1.2.3.2                Deals      178

11.1.2.3.3                Other developments             179

11.1.2.4  MnM view              179

11.1.2.4.1                Right to win           179

11.1.2.4.2                Strategic choices   180

11.1.2.4.3                Weaknesses & competitive threats     180

11.1.3      PROCTER & GAMBLE     181

11.1.3.1  Business overview 181

11.1.3.2  Products offered   182

11.1.3.3  Recent developments           184

11.1.3.3.1                Product launches  184

11.1.3.3.2                Deals      184

11.1.3.4  MnM view              185

11.1.3.4.1                Right to win           185

11.1.3.4.2                Strategic choices   185

11.1.3.4.3                Weaknesses & competitive threats     185

11.1.4      HALEON GROUP OF COMPANIES             186

11.1.4.1  Business overview 186

11.1.4.2  Products offered   187

11.1.4.3  Recent developments           188

11.1.4.3.1                Product launches  188

11.1.4.3.2                Deals      188

11.1.4.3.3                Expansions             189

11.1.4.4  MnM view              189

11.1.4.4.1                Right to win           189

11.1.4.4.2                Strategic choices   190

11.1.4.4.3                Weaknesses & competitive threats     190

11.1.5      UNILEVER           191

11.1.5.1  Business overview 191

11.1.5.2  Products offered   192

11.1.5.3  Recent developments           193

11.1.5.3.1                Deals      193

11.1.5.4  MnM view              193

11.1.5.4.1                Right to win           193

11.1.5.4.2                Strategic choices   193

11.1.5.4.3                Weaknesses & competitive threats     194

11.1.6      CHURCH & DWIGHT CO., INC.   195

11.1.6.1  Business overview 195

11.1.6.2  Products offered   196

11.1.6.3  Recent developments           197

11.1.6.3.1                Product launches  197

11.1.6.3.2                Deals      197

11.1.7      LION CORPORATION     198

11.1.7.1  Business overview 198

11.1.7.2  Products offered   199

11.1.7.3  Recent developments           200

11.1.7.3.1                Product launches  200

11.1.7.3.2                Deals      200

11.1.7.3.3                Expansions             201

11.1.8      AMWAY CORP.  202

11.1.8.1  Business overview 202

11.1.8.2  Products offered   203

11.1.9      SUNSTAR SUISSE S.A.     204

11.1.9.1  Business overview 204

11.1.9.2  Products offered   205

11.1.9.3  Recent developments           206

11.1.9.3.1                Product launches  206

11.1.10   PERRIGO COMPANY PLC              207

11.1.10.1                 Business overview 207

11.1.10.2                 Products offered   208

11.1.10.3                 Recent developments           209

11.1.10.3.1             Deals      209

11.1.11   DABUR 210

11.1.11.1                 Business overview 210

11.1.11.2                 Products offered   211

11.1.11.3                 Recent developments           212

11.1.11.3.1             Deals      212

11.1.12   HIMALAYA WELLNESS COMPANY             213

11.1.12.1                 Business overview 213

11.1.12.2                 Products offered   213

11.1.13   KAO CORPORATION       214

11.1.13.1                 Business overview 214

11.1.13.2                 Products offered   215

11.1.14   OPELLA HEALTHCARE GROUP SAS          216

11.1.14.1                 Business overview 216

11.1.14.2                 Products offered   216

11.1.14.3                 Recent developments           217

11.1.14.3.1             Deals      217

11.1.15   SMARTMOUTH ORAL HEALTH LABORATORIES 218

11.1.15.1                 Business overview 218

11.1.15.2                 Products offered   218

11.1.15.3                 Recent developments           219

11.1.15.3.1             Product launches  219

11.2         OTHER PLAYERS              219

11.2.1      DENTAID             219

11.2.2      CLOSYS 220

11.2.3      SCANDERRA GMBH         221

11.2.4      PEARLIE WHITE                222

11.2.5      WILD     223

11.2.6      BOKA    224

11.2.7      PERFORA             225

11.2.8      SALT ORAL CARE             226

11.2.9      ORABIO                227

11.2.10   LUMINEUX          228

12            APPENDIX           229

12.1         DISCUSSION GUIDE        229

12.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                233

12.3         CUSTOMIZATION OPTIONS        235

12.4         RELATED REPORTS         235

12.5         AUTHOR DETAILS           237

LIST OF TABLES

TABLE 1                ORAL RINSES MARKET: INCLUSIONS & EXCLUSIONS      26

TABLE 2                STANDARD CURRENCY CONVERSION RATES                 27

TABLE 3                ORAL RINSES MARKET: STUDY ASSUMPTIONS                 40

TABLE 4                ORAL RINSES MARKET: RISK ANALYSIS  41

TABLE 5                AVERAGE SELLING PRICE TREND OF ORAL RINSES, BY KEY PLAYER,

2022–2024 (USD)                55

TABLE 6                AVERAGE SELLING PRICE TREND OF ORAL RINSES, BY REGION, 2022–2024 (USD)      56

TABLE 7                ORAL RINSES MARKET: ROLE IN ECOSYSTEM                 57

TABLE 8                ORAL RINSES MARKET: PORTER’S FIVE FORCES                 60

TABLE 9                INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS,

BY DISTRIBUTION CHANNEL     62

TABLE 10              KEY BUYING CRITERIA FOR MAJOR DISTRIBUTION CHANNELS          63

TABLE 11              IMPORT DATA FOR HS CODE 330690, BY COUNTRY,

2020–2024 (USD THOUSAND)      64

TABLE 12              EXPORT DATA FOR HS CODE 330690, BY COUNTRY,

2020–2024 (USD THOUSAND)      65

TABLE 13              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  67

TABLE 14              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  67

TABLE 15              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  68

TABLE 16              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  69

TABLE 17              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 69

TABLE 18              ORAL RINSES MARKET: LIST OF MAJOR PATENTS, 2022–2024        71

TABLE 19              ORAL RINSES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026                 72

TABLE 20              ORAL RINSES MARKET: UNMET NEEDS 74

TABLE 21              ORAL RINSES MARKET: END-USER EXPECTATIONS                75

TABLE 22              CASE STUDY 1: CAPHOSOL ORAL RINSE TO EFFECTIVELY MANAGE CHEMOTHERAPY-INDUCED ORAL MUCOSITIS         76

TABLE 23              CASE STUDY 2: ANTISPETIC MOUTHWASHES TO PREVENT VENTILATOR-ASSOCIATED PNEUMONIA (VAP) AMONG MECHANICALLY VENTILATED PATIENTS           77

TABLE 24              CASE STUDY 3: HERBAL MOUTHRINSE TO BE EFFECIVE FOR CHLORHEXIDINE WITHOUT ADVERSE EFFECTS                 77

TABLE 25              US-ADJUSTED RECIPROCAL TARIFF RATES                 79

TABLE 26              KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR ORAL CARE PRODUCTS       80

TABLE 27              ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)            83

TABLE 28              ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (MILLION UNITS)        83

TABLE 29              THERAPEUTIC ORAL RINSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     84

TABLE 30              COSMETIC ORAL RINSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     85

TABLE 31              OTHER ORAL RINSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            87

TABLE 32              ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION)       89

TABLE 33              ORAL RINSES MARKET FOR GENERAL ORAL HEALTH, BY COUNTRY,

2023–2030 (USD MILLION)            90

TABLE 34              ORAL RINSES MARKET FOR GINGIVITIS & PERIODONTAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)            91

TABLE 35              ORAL RINSES MARKET FOR HALITOSIS, BY COUNTRY, 2023–2030 (USD MILLION)     93

TABLE 36              ORAL RINSES MARKET FOR DRY MOUTH, BY COUNTRY,

2023–2030 (USD MILLION)            94

TABLE 37              ORAL RINSES MARKET FOR OTHER INDICATIONS, BY COUNTRY,

2023–2030 (USD MILLION)            95

TABLE 38              ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION)     97

TABLE 39             ORAL RINSES MARKET FOR CONSUMER STORES, BY COUNTRY,

2023–2030 (USD MILLION)            98

TABLE 40              ORAL RINSES MARKET FOR RETAIL PHARMACIES & DENTAL DISPENSARIES,

BY COUNTRY, 2023–2030 (USD MILLION)               100

TABLE 41              ORAL RINSES MARKET FOR ONLINE DISTRIBUTION, BY COUNTRY,

2023–2030 (USD MILLION)            101

TABLE 42              ORAL RINSES MARKET, BY REGION, 2023–2030 (USD MILLION) 104

TABLE 43              NORTH AMERICA: ORAL RINSES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            106

TABLE 44              NORTH AMERICA: ORAL RINSES MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            106

TABLE 45              NORTH AMERICA: ORAL RINSES MARKET, BY INDICATION,

2023–2030 (USD MILLION)            106

TABLE 46              NORTH AMERICA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            107

TABLE 47              US: KEY MACROINDICATORS     108

TABLE 48              US: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)            108

TABLE 49              US: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION)            108

TABLE 50              US: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            109

TABLE 51              CANADA: KEY MACROINDICATORS         110

TABLE 52              CANADA: ORAL RINSES MARKET, BY PRODUCT TYPE , 2023–2030 (USD MILLION)               110

TABLE 53              CANADA: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION)                110

TABLE 54              CANADA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            111

TABLE 55              EUROPE: ORAL RINSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            112

TABLE 56              EUROPE: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                112

TABLE 57              EUROPE: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION)                113

TABLE 58              EUROPE: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            113

TABLE 59              GERMANY: KEY MACROINDICATORS      114

TABLE 60              GERMANY: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)         114

TABLE 61              GERMANY: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION)                114

TABLE 62              GERMANY: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            115

TABLE 63              UK: KEY MACROINDICATORS     115

TABLE 64              UK: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)            116

TABLE 65              UK: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION)            116

TABLE 66              UK: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            116

TABLE 67              FRANCE: KEY MACROINDICATORS          117

TABLE 68              FRANCE: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                117

TABLE 69              FRANCE: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION)                118

TABLE 70              FRANCE: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            118

TABLE 71              ITALY: KEY MACROINDICATORS               119

TABLE 72              ITALY: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                119

TABLE 73              ITALY: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION)            119

TABLE 74              ITALY: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            120

TABLE 75              SPAIN: KEY MACROINDICATORS               120

TABLE 76              SPAIN: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                121

TABLE 77              SPAIN: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION)            121

TABLE 78              SPAIN: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            121

TABLE 79              SWITZERLAND: KEY MACROINDICATORS                 122

TABLE 80              SWITZERLAND: ORAL RINSES MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            122

TABLE 81              SWITZERLAND: ORAL RINSES MARKET, BY INDICATION,

2023–2030 (USD MILLION)            123

TABLE 82              SWITZERLAND: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            123

TABLE 83              POLAND: KEY MACROINDICATORS         124

TABLE 84              POLAND: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                124

TABLE 85              POLAND: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION)                124

TABLE 86              POLAND: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            125

TABLE 87              REST OF EUROPE: ORAL RINSES MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            125

TABLE 88              REST OF EUROPE: ORAL RINSES MARKET, BY INDICATION,

2023–2030 (USD MILLION)            126

TABLE 89              REST OF EUROPE: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            126

TABLE 90              ASIA PACIFIC: ORAL RINSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     129

TABLE 91              ASIA PACIFIC: ORAL RINSES MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            129

TABLE 92              ASIA PACIFIC: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION)                129

TABLE 93              ASIA PACIFIC: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            130

TABLE 94              CHINA: KEY MACROINDICATORS             130

TABLE 95              CHINA: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                131

TABLE 96              CHINA: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION)            131

TABLE 97              CHINA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            131

TABLE 98              JAPAN: KEY MACROINDICATORS              132

TABLE 99              JAPAN: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                132

TABLE 100            JAPAN: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION)            133

TABLE 101            JAPAN: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            133

TABLE 102            INDIA: KEY MACROINDICATORS               134

TABLE 103            INDIA: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                134

TABLE 104            INDIA: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION)            135

TABLE 105            INDIA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            135

TABLE 106            AUSTRALIA: KEY MACROINDICATORS   136

TABLE 107            AUSTRALIA: ORAL RINSES MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            136

TABLE 108            AUSTRALIA: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION)                136

TABLE 109            AUSTRALIA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            137

TABLE 110            SOUTH KOREA: KEY MACROINDICATORS                 137

TABLE 111            SOUTH KOREA: ORAL RINSES MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            138

TABLE 112            SOUTH KOREA: ORAL RINSES MARKET, BY INDICATION,

2023–2030 (USD MILLION)            138

TABLE 113            SOUTH KOREA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            138

TABLE 114            REST OF ASIA PACIFIC: ORAL RINSES MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            139

TABLE 115            REST OF ASIA PACIFIC: ORAL RINSES MARKET, BY INDICATION,

2023–2030 (USD MILLION)            139

TABLE 116            REST OF ASIA PACIFIC: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION)                 140

TABLE 117            LATIN AMERICA: ORAL RINSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     141

TABLE 118            LATIN AMERICA: ORAL RINSES MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            141

TABLE 119            LATIN AMERICA: ORAL RINSES MARKET, BY INDICATION,

2023–2030 (USD MILLION)            142

TABLE 120            LATIN AMERICA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            142

TABLE 121            BRAZIL: KEY MACROINDICATORS            143

TABLE 122            BRAZIL: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                143

TABLE 123          BRAZIL: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION)            143

TABLE 124            BRAZIL: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            144

TABLE 125            MEXICO: KEY MACROINDICATORS          144

TABLE 126            MEXICO: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                145

TABLE 127            MEXICO: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION)                145

TABLE 128            MEXICO: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            145

TABLE 129            REST OF LATIN AMERICA: ORAL RINSES MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            146

TABLE 130            REST OF LATIN AMERICA: ORAL RINSES MARKET, BY INDICATION,

2023–2030 (USD MILLION)            147

TABLE 131            REST OF LATIN AMERICA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION)            147

TABLE 132            MIDDLE EAST & AFRICA: ORAL RINSES MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            148

TABLE 133            MIDDLE EAST & AFRICA: ORAL RINSES MARKET, BY INDICATION,

2023–2030 (USD MILLION)            149

TABLE 134            MIDDLE EAST & AFRICA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION)                 149

TABLE 135            GCC COUNTRIES: ORAL RINSES MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            150

TABLE 136            GCC COUNTRIES: ORAL RINSES MARKET, BY INDICATION,

2023–2030 (USD MILLION)            151

TABLE 137            GCC COUNTRIES: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            151

TABLE 138            MAJOR STRATEGIES DEPLOYED BY KEY PLAYERS IN ORAL RINSES MARKET, JANUARY 2022–JUNE 2025                 153

TABLE 139            ORLA RINSES MARKET: DEGREE OF COMPETITION 155

TABLE 140            ORAL RINSES MARKET: REGION FOOTPRINT                 160

TABLE 141            ORAL RINSES MARKET: PRODUCT TYPE FOOTPRINT       161

TABLE 142            ORAL RINSES MARKET: INDICATION FOOTPRINT       162

TABLE 143            ORAL RINSES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS             165

TABLE 144            ORAL RINSES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY PRODUCT TYPE AND REGION   165

TABLE 145            ORAL RINSES MARKET: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025              168

TABLE 146            ORAL RINSES MARKET: DEALS, JANUARY 2022–JUNE 2025             169

TABLE 147            ORAL RINSES MARKET: EXPANSIONS, JANUARY 2022–JUNE 2025  170

TABLE 148            ORAL RINSES MARKET: OTHER DEVELOPMENTS,

JANUARY 2022–JUNE 2025              170

TABLE 149            KENVUE: COMPANY OVERVIEW                171

TABLE 150            KENVUE: PRODUCTS OFFERED 172

TABLE 151            KENVUE: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025             174

TABLE 152            KENVUE: DEALS, JANUARY 2022–JUNE 2025                 174

TABLE 153            KENVUE: EXPANSIONS, JANUARY 2022–JUNE 2025        174

TABLE 154            COLGATE-PALMOLIVE COMPANY: COMPANY OVERVIEW          176

TABLE 155            COLGATE-PALMOLIVE COMPANY: PRODUCTS OFFERED             177

TABLE 156            COLGATE-PALMOLIVE COMPANY: PRODUCT LAUNCHES,

JANUARY 2022–JUNE 2025              178

TABLE 157            COLGATE-PALMOLIVE COMPANY: DEALS, JANUARY 2022–JUNE 2025              178

TABLE 158            COLGATE-PALMOLIVE COMPANY: OTHER DEVELOPMENTS,

JANUARY 2022–JUNE 2025              179

TABLE 159            PROCTER & GAMBLE: COMPANY OVERVIEW                 181

TABLE 160            PROCTER & GAMBLE: PRODUCTS OFFERED                 182

TABLE 161            PROCTER & GAMBLE: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025              184

TABLE 162            PROCTER & GAMBLE: DEALS, JANUARY 2022–JUNE 2025             184

TABLE 163            HALEON GROUP OF COMPANIES: COMPANY OVERVIEW          186

TABLE 164            HALEON GROUP OF COMPANIES: PRODUCTS OFFERED             187

TABLE 165            HALEON GROUP OF COMPANIES: PRODUCT LAUNCHES,

JANUARY 2022–JUNE 2025              188

TABLE 166            HALEON GROUP OF COMPANIES: DEALS, JANUARY 2022–JUNE 2025              188

TABLE 167            HALEON GROUP OF COMPANIES: EXPANSIONS, JANUARY 2022–JUNE 2025              189

TABLE 168            UNILEVER: COMPANY OVERVIEW            191

TABLE 169            UNILEVER: PRODUCTS OFFERED             192

TABLE 170            UNILEVER: DEALS, JANUARY 2022–JUNE 2025                 193

TABLE 171            CHURCH & DWIGHT CO., INC.: COMPANY OVERVIEW          195

TABLE 172            CHURCH & DWIGHT CO., INC.: PRODUCTS OFFERED             196

TABLE 173            CHURCH & DWIGHT CO., INC.: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025     197

TABLE 174            CHURCH & DWIGHT CO., INC.: DEALS, JANUARY 2022–JUNE 2025  197

TABLE 175            LION CORPORATION: COMPANY OVERVIEW                 198

TABLE 176            LION CORPORATION: PRODUCTS OFFERED                 199

TABLE 177            LION CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025              200

TABLE 178            LION CORPORATION: DEALS, JANUARY 2022–JUNE 2025             200

TABLE 179            LION CORPORATION: EXPANSIONS, JANUARY 2022–JUNE 2025  201

TABLE 180            AMWAY CORP.: COMPANY OVERVIEW   202

TABLE 181            AMWAY CORP.: PRODUCTS OFFERED    203

TABLE 182            SUNSTAR SUISSE S.A.: COMPANY OVERVIEW                 204

TABLE 183            SUNSTAR SUISSE S.A.: PRODUCTS OFFERED                 205

TABLE 184            SUNSTAR SUISSE S.A.: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025              206

TABLE 185            PERRIGO COMPANY PLC: COMPANY OVERVIEW                 207

TABLE 186            PERRIGO COMPANY PLC: PRODUCTS OFFERED                 208

TABLE 187            PERRIGO COMPANY PLC: DEALS, JANUARY 2022–JUNE 2025  209

TABLE 188            DABUR: COMPANY OVERVIEW  210

TABLE 189            DABUR: PRODUCTS OFFERED   211

TABLE 190            DABUR: DEALS, JANUARY 2022–JUNE 2025                 212

TABLE 191            HIMALAYA WELLNESS COMPANY: COMPANY OVERVIEW          213

TABLE 192            HIMALAYA WELLNESS COMPANY: PRODUCTS OFFERED             213

TABLE 193            KAO CORPORATION: COMPANY OVERVIEW                 214

TABLE 194            KAO CORPORATION: PRODUCTS OFFERED                 215

TABLE 195            OPELLA HEALTHCARE GROUP SAS: COMPANY OVERVIEW          216

TABLE 196            OPELLA HEALTHCARE GROUP SAS: PRODUCTS OFFERED             216

TABLE 197            OPELLA HEALTHCARE GROUP SAS: DEALS, JANUARY 2022–JUNE 2025              217

TABLE 198            SMARTMOUTH ORAL HEALTH LABORATORIES: COMPANY OVERVIEW   218

TABLE 199            SMARTMOUTH ORAL HEALTH LABORATORIES: PRODUCTS OFFERED    218

TABLE 200            SMARTMOUTH ORAL HEALTH LABORATORIES: PRODUCT LAUNCHES,

JANUARY 2022–JUNE 2025              219

TABLE 201            DENTAID: COMPANY OVERVIEW              219

TABLE 202            CLOSYS: COMPANY OVERVIEW 220

TABLE 203            SCANDERRA GMBH: COMPANY OVERVIEW                 221

TABLE 204            PEARLIE WHITE: COMPANY OVERVIEW 222

TABLE 205            WILD: COMPANY OVERVIEW      223

TABLE 206            BOKA: COMPANY OVERVIEW     224

TABLE 207            PERFORA: COMPANY OVERVIEW              225

TABLE 208            SALT ORAL CARE: COMPANY OVERVIEW                 226

TABLE 209            ORABIO: COMPANY OVERVIEW 227

TABLE 210            LUMINEUX: COMPANY OVERVIEW          228

LIST OF FIGURES

FIGURE 1              ORAL RINSES MARKET SEGMENTATION & REGIONAL SCOPE            25

FIGURE 2              ORAL RINSES MARKET: YEARS CONSIDERED                 27

FIGURE 3              ORAL RINSES MARKET: RESEARCH DESIGN                 29

FIGURE 4              ORAL RINSES MARKET: KEY DATA FROM SECONDARY SOURCES  31

FIGURE 5              ORAL RINSES MARKET: KEY PRIMARY DATA SOURCES             31

FIGURE 6              ORAL RINSES MARKET: KEY DATA FROM PRIMARY SOURCES         32

FIGURE 7              ORAL RINSES MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS       33

FIGURE 8              BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND

DEMAND-SIDE PARTICIPANTS  33

FIGURE 9              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,

DESIGNATION, AND REGION     34

FIGURE 10            ORAL RINSES SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2024) 35

FIGURE 11            REVENUE SHARE ANALYSIS FOR HALEON GROUP OF COMPANIES (2024)   35

FIGURE 12            ORAL RINSES MARKET: SUPPLY-SIDE ANALYSIS (2024)    36

FIGURE 13            ORAL RINSES MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS)             36

FIGURE 14            ORAL RINSES MARKET: BOTTOM-UP APPROACH (SUPPLY-SIDE ANALYSIS)    37

FIGURE 15            CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS,

OPPORTUNITIES, AND CHALLENGES (2025–2030)              38

FIGURE 16            ORAL RINSES MARKET: TOP-DOWN APPROACH                 39

FIGURE 17            ORAL RINSES MARKET: DATA TRIANGULATION METHODOLOGY              40

FIGURE 20            ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,

2025 VS. 2030 (USD MILLION)      43

FIGURE 21            ORAL RINSES MARKET: REGIONAL SNAPSHOT                 44

FIGURE 22            RISING AWARENESS OF PREVENTIVE DENTAL CARE AND ORAL

HYGIENE TO DRIVE MARKET     45

FIGURE 23            JAPAN AND THERAPEUTIC RINSES ACCOUNTED FOR LARGEST ASIA PACIFIC ORAL RINSES MARKET SHARE IN 2024 46

FIGURE 24            INDIA TO GROW AT HIGHEST CAGR DURING STUDY PERIOD 47

FIGURE 25            NORTH AMERICA TO COMMAND LARGEST MARKET SHARE

DURING FORECAST PERIOD       47

FIGURE 26            EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES FROM

2025 TO 2030       48

FIGURE 27            ORAL RINSES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          49

FIGURE 28            ORAL RINSES MARKET: ECOSYSTEM ANALYSIS                 57

FIGURE 29            ORAL RINSES MARKET: VALUE CHAIN ANALYSIS                 59

FIGURE 30            ORAL RINSES MARKET: PORTER’S FIVE FORCES ANALYSIS            60

FIGURE 31            INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY DISTRIBUTION CHANNEL               62

FIGURE 32            KEY BUYING CRITERIA FOR MAJOR DISTRIBUTION CHANNELS          62

FIGURE 33            ORAL RINSES MARKET: SUPPLY CHAIN ANALYSIS            64

FIGURE 34            TOP PATENT APPLICANTS/OWNERS (COMPANIES/INSTITUTES) FOR ORAL RINSES MARKET (JANUARY 2014–DECEMBER 2024)              70

FIGURE 35            TOP PATENT APPLICANT COUNTRIES FOR ORAL RINSES MARKET

(JANUARY 2014–DECEMBER 2024)              71

FIGURE 36            MARKETS ADJACENT TO ORAL RINSES MARKET                 73

FIGURE 37            ORAL RINSES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73

FIGURE 38            ORAL RINSES MARKET: FUNDING AND NUMBER OF DEALS, 2019–2023       78

FIGURE 39            ORAL RINSES MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES         103

FIGURE 40            NORTH AMERICA: ORAL RINSES MARKET SNAPSHOT          105

FIGURE 41            ASIA PACIFIC: ORAL RINSES MARKET SNAPSHOT          128

FIGURE 42            REVENUE SHARE ANALYSIS OF KEY PLAYERS IN ORAL RINSES

MARKET (2020–2024)       154

FIGURE 43            MARKET SHARE ANALYSIS OF KEY PLAYERS IN ORAL RINSES MARKET (2024)      155

FIGURE 44            ORAL RINSES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024         157

FIGURE 45            ORAL RINSES MARKET: COMPANY FOOTPRINT                 159

FIGURE 46            ORAL RINSES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 164

FIGURE 47            EV/EBITDA OF KEY VENDORS   166

FIGURE 48            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF

KEY VENDORS  166

FIGURE 49            ORAL RINSES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS            167

FIGURE 50            ORAL RINSES MARKET: R&D EXPENDITURE OF KEY PLAYERS (2022–2024)              168

FIGURE 51            KENVUE: COMPANY SNAPSHOT                172

FIGURE 52            COLGATE-PALMOLIVE COMPANY: COMPANY SNAPSHOT          177

FIGURE 53            PROCTER & GAMBLE: COMPANY SNAPSHOT                 182

FIGURE 54            HALEON GROUP OF COMPANIES: COMPANY SNAPSHOT          187

FIGURE 55            UNILEVER: COMPANY SNAPSHOT            192

FIGURE 56            CHURCH & DWIGHT CO., INC.: COMPANY SNAPSHOT          196

FIGURE 57            LION CORPORATION: COMPANY SNAPSHOT                 199

FIGURE 58            AMWAY CORP.: COMPANY SNAPSHOT   202

FIGURE 59            SUNSTAR SUISSE S.A.: COMPANY SNAPSHOT                 205

FIGURE 60            PERRIGO COMPANY PLC: COMPANY SNAPSHOT                 208

FIGURE 61            DABUR: COMPANY SNAPSHOT  211

FIGURE 62            KAO CORPORATION: COMPANY SNAPSHOT                 215

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧